Company profile
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2016 average
Name
Price
%
Turn. (tEUR)
-
1,002
0.00
6
^
208
+0.48
47
ˇ
153
-1.29
3
ˇ
22,295
-1.35
1
^
754
+0.40
22
-
2,320
0.00
1
ˇ
13,535
-0.15
2,033
-
387
0.00
1,151
^
5,850
+1.74
9,106
ˇ
330
-0.60
12
ˇ
1,260
-0.79
3
^
5,000
+0.75
7,637
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
22,702.11
166.08 (0.74)
1,634.69
-0.49 (-0.03)
1,499.07
-14.67 (-0.97)